The Impact of Delayed Diagnosis of Alpha-1 Antitrypsin Deficiency

Completed

Conditions studied: Alpha 1-Antitrypsin Deficiency

In brief

The objective of this study is to prospectively assess whether there is any interval between first symptom and initial diagnosis that is experienced by patients with newly diagnosed alpha-1 antitrypsin deficiency (AATD) and then to assess whether this diagnostic interval is associated with worsened clinical status at the time of initial diagnosis.

Key facts

Study ID

NCT03039335

Run by

Biocerna LLC

People needed

43

Starts

2016-12-15

Expected to finish

2018-04-15

Last updated by the study team

2018-07-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years of age or older
• Positive AATD Test Result

You may not qualify if…

• Previous Positive AATD Test Result
• Negative Test Result for AATD

Where it is running

• Biocerna LLC — Fulton, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.